An independently validated nomogram for individualized estimation of survival among patients with newly diagnosed glioblastoma: NRG Oncology RTOG 0525 and 0825

BACKGROUND. Glioblastoma (GBM) is the most common primary malignant brain tumor. Nomograms are often used for individualized estimation of prognosis. This study aimed to build and independently validate a nomogram to estimate individualized survival probabilities for patients with newly diagnosed GB...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Neuro Oncol
Autors principals: Gittleman, Haley, Lim, Daniel, Kattan, Michael W., Chakravarti, Arnab, Gilbert, Mark R., Lassman, Andrew B., Lo, Simon S., Machtay, Mitchell, Sloan, Andrew E., Sulman, Erik P, Tian, Devin, Vogelbaum, Michael A., Wang, Tony J. C., Penas-Prado, Marta, Youssef, Emad, Blumenthal, Deborah T., Zhang, Peixin, Mehta, Minesh P., Barnholtz-Sloan, Jill S.
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2017
Matèries:
Clinical Investigations
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5464437/
https://ncbi.nlm.nih.gov/pubmed/28453749
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/now208
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars